Suven Pharmaceuticals Outperforms Sector with Notable Stock Gains and Long-Term Growth

Suven Pharmaceuticals has shown significant activity today, with the stock rising by 5.55% on April 3, 2025. This performance has allowed the company to outperform its sector, which gained 4.06%, by 1.78%. Over the past two days, Suven Pharmaceuticals has recorded a consecutive gain, accumulating a total return of 6.3%.
The stock reached an intraday high of Rs 1149.85, reflecting a 5.98% increase. In terms of moving averages, the stock is currently above its 5-day, 50-day, and 200-day moving averages, although it remains below the 20-day and 100-day moving averages.

When examining Suven Pharmaceuticals' performance over various time frames, the company has demonstrated resilience. Over the past year, it has achieved a remarkable 72.01% increase, significantly outpacing the Sensex, which has only risen by 3.11% during the same period. Additionally, the stock has shown impressive long-term growth, with a staggering 941.74% increase over the past five years, compared to the Sensex's 176.07%.